Incidence of intravenous (IV) hydration post anthracycline-cyclophosphamide (AC) chemotherapy in breast cancer patients

被引：0

作者：

Navari, Rudolph M. ^{[1
,2
]}

Mosier, Michael C. ^{[3
]}

机构：

[1] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA

[2] World Hlth Org, Canc Care Program, Birmingham, AL USA

[3] EMB Stat Solut LLC, Overland Pk, KS USA

来源：

CANCER RESEARCH | 2021年 / 81卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PS9-61

引用

页数：2

共 50 条

[1] Antiemetic efficacy of intravenous (IV) NEPA in patients with breast cancer (BC) receiving anthracycline/cyclophosphamide (AC) chemotherapy.
Schwartzberg, Lee S.
Aapro, Matti S.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31)
[2] Safety of intravenous (IV) NEPA and oral NEPA for prevention of CINV in patients (pts) with breast cancer (BC) receiving anthracycline/cyclophosphamide (AC) chemotherapy (CT).
Schwartzberg, Lee S.
Voisin, Daniel
Rizzi, Giada
Patel, Kamal
Aapro, Matti S.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[3] Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving anthracycline-cyclophosphamide (AC)-based chemotherapy
Schnadig, Ian D.
Modiano, Manuel R.
Poma, Allen
Arora, Sujata
Schwartzberg, Lee Steven
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[4] Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving anthracycline-cyclophosphamide (AC) based chemotherapy.
Powers, Daniel
Schnadig, Ian D.
Modiano, Manuel R.
Arora, Sujata
Schwartzberg, Lee Steven
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
[5] EFFICACY OF NEPA, THE FIRST COMBINATION ANTIEMETIC AGENT, IN PATIENTS WITH BREAST CANCER RECEIVING ANTHRACYCLINE/CYCLOPHOSPHAMIDE (AC) OR NON-AC CHEMOTHERAPY
Rugo, Hope
Aapro, Matti
Rossi, Giorgia
Rizzi, Giada
BREAST, 2015, 24 : S60 - S60
[6] Association of oral mucositis induced by anthracycline-cyclophosphamide and subsequent docetaxel treatment for perioperative breast cancer
Saito, Yoshitaka
Takekuma, Yoh
Takahashi, Masato
Oshino, Tomohiro
Sugawara, Mitsuru
SUPPORTIVE CARE IN CANCER, 2024, 32 (08)
[7] Control of Nausea and Vomiting in Patients Receiving Anthracycline/Cyclophosphamide Chemotherapy for Breast Cancer
Nawa-Nishigaki, Minako
Kobayashi, Ryo
Suzuki, Akio
Hirose, Chiemi
Matsuoka, Rie
Mori, Ryutaro
Futamura, Manabu
Sugiyama, Tadashi
Yoshida, Kazuhiro
Itoh, Yoshinori
ANTICANCER RESEARCH, 2018, 38 (02) : 877 - 884
[8] Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer
Veronese, Pedro
Hachul, Denise Tessariol
Scanavacca, Mauricio Ibrahim
Hajjar, Ludhmila Abrahao
Wu, Tan Chen
Sacilotto, Luciana
Veronese, Carolina
da Costa Darrieux, Francisco Carlos
PLOS ONE, 2018, 13 (05):
[9] Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy
Schwartzberg, Lee
Navari, Rudolph
Clark-Snow, Rebecca
Arkania, Ekaterine
Radyukova, Irena
Patel, Kamal
Voisin, Daniel
Rizzi, Giada
Wickham, Rita
Gralla, Richard J.
Aapro, Matti
Roeland, Eric
ONCOLOGIST, 2020, 25 (03): : E589 - E597
[10] Hepatotoxicity of anthracycline chemotherapy in patients with breast cancer
Guskova, Nailya
Kit, Oleg I.
Vladimirova, Liubov Yu
Tikhanovskaya, Natalya Mikhailovna
Sycheva, Elena A.
Nozdricheva, Anastasia
Abakumova, Svetlana V.
Abramova, Natalya A.
Storozhakova, Anna E.
Popova, Irina L.
Ryadinskaya, Ludmila A.
Lyanova, Aza A.
Novoselova, Kristina A.
Lisunova, Zinaida P.
Avanesova, Kristina
Zekhtser, Ineya I.
Belgova, Svetlana V.
Zakharchenko, Viktoria
Tselishcheva, Irina V.
Torpudzhyan, Izabella
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

← 1 2 3 4 5 →